Extractor: pypdf | Pages: 19
1 ORDER of the Court of Appeal of the Unified Patent Court issued on 13 August 2025 concerning an Application for provisional measures (R. 206 RoP) HEADNOTES: - In the context of marketing of generic medicines, the mere application for a marketing authorisation by a generics company does not amount to an imminent infringement, nor does the grant of such an authorisation create one. - Completion of the national procedures for health technology assessment, pricing and reimbursement for a generic medicine can amount to an imminent infringement. The assessment must be made with due regard to the national regulatory and legislative context and considering the circumstances of the case. - A request for an order to communicate information in a case of alleged imminent infringement has been denied ...